ALSE

 
Common Stock Dark or Defunct
Pink No Information
Contact Info
  • 275 Grove Street
  • Sute 2-400
  • Auburndale, MA 92466

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Nov 18, 2014
Audited Financials Audited
Latest Report Jun 30, 2014 10-Q
CIK 0000094784
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Kenneth L. Rice CFO, EVP
Company Directors
William Guinness
Michael Mullen
Peter Savas
Service Providers
Accounting/Auditing Firm
McGladrey & Pullen, LLP
One Valley Square, Suite 250
512 Township Line Rd.
Blue Bell, PA, 19422-2700
United States
 
Securities Counsel
Wilmer Hale LLC
60 State Street
Boston, MA, 02109
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Boston Life Sciences, Inc. until 6-07
  • Formerly=Greenwich Pharmaceuticals, Inc. until 6-95
ALSE Security Details
Share Structure
Market Value1 Not Available
Authorized Shares Not Available
Outstanding Shares Not Available
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 900 (-93.09%)
Dec 15, 2014
Significant Failures to Deliver No

1Market Value calculated only for respective security